nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ORM1—Erlotinib—pancreatic cancer	0.11	0.141	CbGbCtD
Abiraterone—ABCC1—Epirubicin—pancreatic cancer	0.0933	0.12	CbGbCtD
Abiraterone—ABCC1—Irinotecan—pancreatic cancer	0.0908	0.116	CbGbCtD
Abiraterone—ABCC1—Docetaxel—pancreatic cancer	0.0665	0.0853	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—pancreatic cancer	0.0496	0.0636	CbGbCtD
Abiraterone—ALB—Erlotinib—pancreatic cancer	0.0464	0.0594	CbGbCtD
Abiraterone—CYP2C8—Tamoxifen—pancreatic cancer	0.0421	0.054	CbGbCtD
Abiraterone—ALB—Irinotecan—pancreatic cancer	0.0419	0.0537	CbGbCtD
Abiraterone—ALB—Fluorouracil—pancreatic cancer	0.0402	0.0515	CbGbCtD
Abiraterone—CYP2C8—Erlotinib—pancreatic cancer	0.0358	0.0459	CbGbCtD
Abiraterone—CYP2C8—Fluorouracil—pancreatic cancer	0.0311	0.0398	CbGbCtD
Abiraterone—CYP2D6—Tamoxifen—pancreatic cancer	0.0269	0.0344	CbGbCtD
Abiraterone—CYP2D6—Erlotinib—pancreatic cancer	0.0229	0.0293	CbGbCtD
Abiraterone—CYP3A4—Tamoxifen—pancreatic cancer	0.0171	0.0219	CbGbCtD
Abiraterone—CYP3A4—Erlotinib—pancreatic cancer	0.0145	0.0186	CbGbCtD
Abiraterone—CYP3A4—Irinotecan—pancreatic cancer	0.0131	0.0168	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—pancreatic cancer	0.0113	0.0145	CbGbCtD
Abiraterone—CYP3A4—Docetaxel—pancreatic cancer	0.00962	0.0123	CbGbCtD
Abiraterone—CYP3A4—Sunitinib—pancreatic cancer	0.00958	0.0123	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—pancreatic cancer	0.00717	0.00919	CbGbCtD
Abiraterone—ORM1—bile—pancreatic cancer	0.00169	0.508	CbGeAlD
Abiraterone—SULT2A1—digestive system—pancreatic cancer	0.000603	0.182	CbGeAlD
Abiraterone—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000513	0.00237	CcSEcCtD
Abiraterone—Urethral disorder—Gemcitabine—pancreatic cancer	0.000512	0.00237	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—pancreatic cancer	0.000497	0.0023	CcSEcCtD
Abiraterone—Cardiac disorder—Irinotecan—pancreatic cancer	0.000497	0.0023	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—pancreatic cancer	0.000496	0.00229	CcSEcCtD
Abiraterone—Cough—Sunitinib—pancreatic cancer	0.000494	0.00228	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000492	0.00227	CcSEcCtD
Abiraterone—Hypertension—Sunitinib—pancreatic cancer	0.000489	0.00226	CcSEcCtD
Abiraterone—Insomnia—Tamoxifen—pancreatic cancer	0.000488	0.00226	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000486	0.00225	CcSEcCtD
Abiraterone—Angiopathy—Irinotecan—pancreatic cancer	0.000486	0.00225	CcSEcCtD
Abiraterone—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000484	0.00224	CcSEcCtD
Abiraterone—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000483	0.00223	CcSEcCtD
Abiraterone—Insomnia—Erlotinib—pancreatic cancer	0.000483	0.00223	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000482	0.00223	CcSEcCtD
Abiraterone—Chest pain—Sunitinib—pancreatic cancer	0.000482	0.00223	CcSEcCtD
Abiraterone—Myalgia—Sunitinib—pancreatic cancer	0.000482	0.00223	CcSEcCtD
Abiraterone—Dyspnoea—Tamoxifen—pancreatic cancer	0.000481	0.00222	CcSEcCtD
Abiraterone—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000479	0.00221	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000479	0.00221	CcSEcCtD
Abiraterone—Arrhythmia—Irinotecan—pancreatic cancer	0.000479	0.00221	CcSEcCtD
Abiraterone—Dyspnoea—Erlotinib—pancreatic cancer	0.000476	0.0022	CcSEcCtD
Abiraterone—Dyspepsia—Tamoxifen—pancreatic cancer	0.000475	0.0022	CcSEcCtD
Abiraterone—Angiopathy—Gemcitabine—pancreatic cancer	0.000474	0.00219	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—pancreatic cancer	0.000472	0.00218	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000472	0.00218	CcSEcCtD
Abiraterone—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00047	0.00217	CcSEcCtD
Abiraterone—Dyspepsia—Erlotinib—pancreatic cancer	0.00047	0.00217	CcSEcCtD
Abiraterone—ORM1—gall bladder—pancreatic cancer	0.000468	0.141	CbGeAlD
Abiraterone—Arrhythmia—Gemcitabine—pancreatic cancer	0.000466	0.00216	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000466	0.00215	CcSEcCtD
Abiraterone—Fatigue—Tamoxifen—pancreatic cancer	0.000465	0.00215	CcSEcCtD
Abiraterone—Oedema—Sunitinib—pancreatic cancer	0.000462	0.00214	CcSEcCtD
Abiraterone—Constipation—Tamoxifen—pancreatic cancer	0.000461	0.00213	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000461	0.00213	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—pancreatic cancer	0.00046	0.00213	CcSEcCtD
Abiraterone—Fatigue—Erlotinib—pancreatic cancer	0.00046	0.00213	CcSEcCtD
Abiraterone—Infection—Sunitinib—pancreatic cancer	0.000459	0.00212	CcSEcCtD
Abiraterone—Arrhythmia—Fluorouracil—pancreatic cancer	0.000458	0.00212	CcSEcCtD
Abiraterone—Constipation—Erlotinib—pancreatic cancer	0.000456	0.00211	CcSEcCtD
Abiraterone—Skin disorder—Sunitinib—pancreatic cancer	0.000449	0.00207	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—pancreatic cancer	0.000437	0.00202	CcSEcCtD
Abiraterone—Anaemia—Irinotecan—pancreatic cancer	0.000431	0.00199	CcSEcCtD
Abiraterone—Body temperature increased—Erlotinib—pancreatic cancer	0.000422	0.00195	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000421	0.00195	CcSEcCtD
Abiraterone—Anaemia—Gemcitabine—pancreatic cancer	0.00042	0.00194	CcSEcCtD
Abiraterone—Insomnia—Sunitinib—pancreatic cancer	0.000418	0.00193	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.000415	0.00192	CcSEcCtD
Abiraterone—Pneumonia—Docetaxel—pancreatic cancer	0.000415	0.00192	CcSEcCtD
Abiraterone—Anaemia—Fluorouracil—pancreatic cancer	0.000413	0.00191	CcSEcCtD
Abiraterone—Infestation NOS—Docetaxel—pancreatic cancer	0.000413	0.00191	CcSEcCtD
Abiraterone—Infestation—Docetaxel—pancreatic cancer	0.000413	0.00191	CcSEcCtD
Abiraterone—Dyspnoea—Sunitinib—pancreatic cancer	0.000412	0.0019	CcSEcCtD
Abiraterone—ALB—gall bladder—pancreatic cancer	0.000411	0.124	CbGeAlD
Abiraterone—Cough—Irinotecan—pancreatic cancer	0.000407	0.00188	CcSEcCtD
Abiraterone—Dyspepsia—Sunitinib—pancreatic cancer	0.000407	0.00188	CcSEcCtD
Abiraterone—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000407	0.00188	CcSEcCtD
Abiraterone—Myocardial infarction—Docetaxel—pancreatic cancer	0.000404	0.00187	CcSEcCtD
Abiraterone—Hypertension—Irinotecan—pancreatic cancer	0.000403	0.00186	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000399	0.00184	CcSEcCtD
Abiraterone—Fatigue—Sunitinib—pancreatic cancer	0.000398	0.00184	CcSEcCtD
Abiraterone—Cough—Gemcitabine—pancreatic cancer	0.000396	0.00183	CcSEcCtD
Abiraterone—Constipation—Sunitinib—pancreatic cancer	0.000395	0.00183	CcSEcCtD
Abiraterone—Discomfort—Irinotecan—pancreatic cancer	0.000392	0.00181	CcSEcCtD
Abiraterone—Hypertension—Gemcitabine—pancreatic cancer	0.000392	0.00181	CcSEcCtD
Abiraterone—Asthenia—Tamoxifen—pancreatic cancer	0.000387	0.00179	CcSEcCtD
Abiraterone—Myalgia—Gemcitabine—pancreatic cancer	0.000387	0.00179	CcSEcCtD
Abiraterone—Chest pain—Gemcitabine—pancreatic cancer	0.000387	0.00179	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—pancreatic cancer	0.000386	0.00178	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000384	0.00178	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000384	0.00178	CcSEcCtD
Abiraterone—Asthenia—Erlotinib—pancreatic cancer	0.000383	0.00177	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—pancreatic cancer	0.000383	0.00177	CcSEcCtD
Abiraterone—Discomfort—Gemcitabine—pancreatic cancer	0.000382	0.00177	CcSEcCtD
Abiraterone—Oedema—Irinotecan—pancreatic cancer	0.000381	0.00176	CcSEcCtD
Abiraterone—Chest pain—Fluorouracil—pancreatic cancer	0.00038	0.00176	CcSEcCtD
Abiraterone—Myalgia—Fluorouracil—pancreatic cancer	0.00038	0.00176	CcSEcCtD
Abiraterone—Infection—Irinotecan—pancreatic cancer	0.000378	0.00175	CcSEcCtD
Abiraterone—Discomfort—Fluorouracil—pancreatic cancer	0.000376	0.00174	CcSEcCtD
Abiraterone—Oedema—Gemcitabine—pancreatic cancer	0.000371	0.00171	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—pancreatic cancer	0.00037	0.00171	CcSEcCtD
Abiraterone—Diarrhoea—Tamoxifen—pancreatic cancer	0.000369	0.00171	CcSEcCtD
Abiraterone—Infection—Gemcitabine—pancreatic cancer	0.000368	0.0017	CcSEcCtD
Abiraterone—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000366	0.00169	CcSEcCtD
Abiraterone—Body temperature increased—Sunitinib—pancreatic cancer	0.000365	0.00169	CcSEcCtD
Abiraterone—Diarrhoea—Erlotinib—pancreatic cancer	0.000365	0.00169	CcSEcCtD
Abiraterone—Oedema—Fluorouracil—pancreatic cancer	0.000365	0.00169	CcSEcCtD
Abiraterone—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000364	0.00168	CcSEcCtD
Abiraterone—Urethral disorder—Docetaxel—pancreatic cancer	0.000363	0.00168	CcSEcCtD
Abiraterone—Infection—Fluorouracil—pancreatic cancer	0.000362	0.00167	CcSEcCtD
Abiraterone—Skin disorder—Gemcitabine—pancreatic cancer	0.00036	0.00166	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—pancreatic cancer	0.000357	0.00165	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000354	0.00164	CcSEcCtD
Abiraterone—Insomnia—Irinotecan—pancreatic cancer	0.000344	0.00159	CcSEcCtD
Abiraterone—Cardiac disorder—Docetaxel—pancreatic cancer	0.000344	0.00159	CcSEcCtD
Abiraterone—Vomiting—Tamoxifen—pancreatic cancer	0.000343	0.00159	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—pancreatic cancer	0.000342	0.00158	CcSEcCtD
Abiraterone—Rash—Tamoxifen—pancreatic cancer	0.00034	0.00157	CcSEcCtD
Abiraterone—Dermatitis—Tamoxifen—pancreatic cancer	0.00034	0.00157	CcSEcCtD
Abiraterone—Vomiting—Erlotinib—pancreatic cancer	0.000339	0.00157	CcSEcCtD
Abiraterone—Dyspnoea—Irinotecan—pancreatic cancer	0.000339	0.00157	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000338	0.00156	CcSEcCtD
Abiraterone—Rash—Erlotinib—pancreatic cancer	0.000337	0.00156	CcSEcCtD
Abiraterone—Dermatitis—Erlotinib—pancreatic cancer	0.000336	0.00155	CcSEcCtD
Abiraterone—Angiopathy—Docetaxel—pancreatic cancer	0.000336	0.00155	CcSEcCtD
Abiraterone—Insomnia—Gemcitabine—pancreatic cancer	0.000335	0.00155	CcSEcCtD
Abiraterone—Dyspepsia—Irinotecan—pancreatic cancer	0.000335	0.00155	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000334	0.00154	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000332	0.00154	CcSEcCtD
Abiraterone—Asthenia—Sunitinib—pancreatic cancer	0.000332	0.00153	CcSEcCtD
Abiraterone—Arrhythmia—Docetaxel—pancreatic cancer	0.000331	0.00153	CcSEcCtD
Abiraterone—Dyspnoea—Gemcitabine—pancreatic cancer	0.000331	0.00153	CcSEcCtD
Abiraterone—Insomnia—Fluorouracil—pancreatic cancer	0.00033	0.00152	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—pancreatic cancer	0.000329	0.00152	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000329	0.00152	CcSEcCtD
Abiraterone—Fatigue—Irinotecan—pancreatic cancer	0.000328	0.00152	CcSEcCtD
Abiraterone—Constipation—Irinotecan—pancreatic cancer	0.000326	0.0015	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000325	0.0015	CcSEcCtD
Abiraterone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000325	0.0015	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—pancreatic cancer	0.000324	0.0015	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000323	0.00149	CcSEcCtD
Abiraterone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000321	0.00148	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00032	0.00148	CcSEcCtD
Abiraterone—Fatigue—Gemcitabine—pancreatic cancer	0.00032	0.00148	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000318	0.00147	CcSEcCtD
Abiraterone—Constipation—Gemcitabine—pancreatic cancer	0.000317	0.00147	CcSEcCtD
Abiraterone—Diarrhoea—Sunitinib—pancreatic cancer	0.000316	0.00146	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000315	0.00146	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000304	0.00141	CcSEcCtD
Abiraterone—Body temperature increased—Irinotecan—pancreatic cancer	0.000301	0.00139	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000301	0.00139	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000299	0.00138	CcSEcCtD
Abiraterone—Anaemia—Docetaxel—pancreatic cancer	0.000298	0.00138	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000295	0.00136	CcSEcCtD
Abiraterone—Vomiting—Sunitinib—pancreatic cancer	0.000294	0.00136	CcSEcCtD
Abiraterone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000293	0.00136	CcSEcCtD
Abiraterone—Rash—Sunitinib—pancreatic cancer	0.000291	0.00135	CcSEcCtD
Abiraterone—Dermatitis—Sunitinib—pancreatic cancer	0.000291	0.00135	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.00029	0.00134	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—pancreatic cancer	0.000288	0.00133	CcSEcCtD
Abiraterone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000288	0.00133	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000282	0.0013	CcSEcCtD
Abiraterone—Cough—Docetaxel—pancreatic cancer	0.000281	0.0013	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—pancreatic cancer	0.00028	0.00129	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—pancreatic cancer	0.000278	0.00129	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—pancreatic cancer	0.000278	0.00129	CcSEcCtD
Abiraterone—Infestation—Epirubicin—pancreatic cancer	0.000278	0.00129	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—pancreatic cancer	0.000274	0.00127	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—pancreatic cancer	0.000274	0.00127	CcSEcCtD
Abiraterone—Asthenia—Irinotecan—pancreatic cancer	0.000273	0.00126	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000273	0.00126	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—pancreatic cancer	0.00027	0.00125	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000268	0.00124	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—pancreatic cancer	0.000267	0.00123	CcSEcCtD
Abiraterone—Asthenia—Gemcitabine—pancreatic cancer	0.000266	0.00123	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—pancreatic cancer	0.000265	0.00123	CcSEcCtD
Abiraterone—Oedema—Docetaxel—pancreatic cancer	0.000263	0.00122	CcSEcCtD
Abiraterone—Infection—Docetaxel—pancreatic cancer	0.000261	0.00121	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00026	0.0012	CcSEcCtD
Abiraterone—Diarrhoea—Irinotecan—pancreatic cancer	0.00026	0.0012	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—pancreatic cancer	0.000259	0.0012	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000257	0.00119	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—pancreatic cancer	0.000257	0.00119	CcSEcCtD
Abiraterone—Skin disorder—Docetaxel—pancreatic cancer	0.000256	0.00118	CcSEcCtD
Abiraterone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000254	0.00117	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00025	0.00116	CcSEcCtD
Abiraterone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000249	0.00115	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000247	0.00114	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—pancreatic cancer	0.000245	0.00113	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000245	0.00113	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—pancreatic cancer	0.000245	0.00113	CcSEcCtD
Abiraterone—Vomiting—Irinotecan—pancreatic cancer	0.000242	0.00112	CcSEcCtD
Abiraterone—Rash—Irinotecan—pancreatic cancer	0.00024	0.00111	CcSEcCtD
Abiraterone—Dermatitis—Irinotecan—pancreatic cancer	0.00024	0.00111	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00024	0.00111	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—pancreatic cancer	0.000238	0.0011	CcSEcCtD
Abiraterone—Vomiting—Gemcitabine—pancreatic cancer	0.000236	0.00109	CcSEcCtD
Abiraterone—Dyspnoea—Docetaxel—pancreatic cancer	0.000235	0.00108	CcSEcCtD
Abiraterone—Rash—Gemcitabine—pancreatic cancer	0.000234	0.00108	CcSEcCtD
Abiraterone—Dermatitis—Gemcitabine—pancreatic cancer	0.000234	0.00108	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000232	0.00107	CcSEcCtD
Abiraterone—Vomiting—Fluorouracil—pancreatic cancer	0.000232	0.00107	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—pancreatic cancer	0.000232	0.00107	CcSEcCtD
Abiraterone—Rash—Fluorouracil—pancreatic cancer	0.00023	0.00106	CcSEcCtD
Abiraterone—Dermatitis—Fluorouracil—pancreatic cancer	0.00023	0.00106	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000228	0.00106	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000227	0.00105	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000227	0.00105	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—pancreatic cancer	0.000227	0.00105	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—pancreatic cancer	0.000227	0.00105	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000227	0.00105	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000225	0.00104	CcSEcCtD
Abiraterone—Constipation—Docetaxel—pancreatic cancer	0.000225	0.00104	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—pancreatic cancer	0.000223	0.00103	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—pancreatic cancer	0.000219	0.00101	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000215	0.000992	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—pancreatic cancer	0.00021	0.000969	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000208	0.000963	CcSEcCtD
Abiraterone—Body temperature increased—Docetaxel—pancreatic cancer	0.000208	0.000962	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—pancreatic cancer	0.000206	0.000955	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—pancreatic cancer	0.000203	0.000936	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—pancreatic cancer	0.000201	0.000929	CcSEcCtD
Abiraterone—Cough—Epirubicin—pancreatic cancer	0.00019	0.000877	CcSEcCtD
Abiraterone—Asthenia—Docetaxel—pancreatic cancer	0.000189	0.000873	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—pancreatic cancer	0.000188	0.000868	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—pancreatic cancer	0.000186	0.00086	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—pancreatic cancer	0.000185	0.000856	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—pancreatic cancer	0.000185	0.000856	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000184	0.00085	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—pancreatic cancer	0.000183	0.000846	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—pancreatic cancer	0.00018	0.000832	CcSEcCtD
Abiraterone—Oedema—Epirubicin—pancreatic cancer	0.000177	0.00082	CcSEcCtD
Abiraterone—Infection—Epirubicin—pancreatic cancer	0.000176	0.000815	CcSEcCtD
Abiraterone—Cough—Doxorubicin—pancreatic cancer	0.000176	0.000812	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—pancreatic cancer	0.000174	0.000803	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—pancreatic cancer	0.000172	0.000797	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—pancreatic cancer	0.000171	0.000792	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—pancreatic cancer	0.000171	0.000792	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00017	0.000786	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—pancreatic cancer	0.000169	0.000782	CcSEcCtD
Abiraterone—Vomiting—Docetaxel—pancreatic cancer	0.000167	0.000773	CcSEcCtD
Abiraterone—Rash—Docetaxel—pancreatic cancer	0.000166	0.000767	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—pancreatic cancer	0.000166	0.000766	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—pancreatic cancer	0.000164	0.000759	CcSEcCtD
Abiraterone—Infection—Doxorubicin—pancreatic cancer	0.000163	0.000754	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000162	0.000748	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—pancreatic cancer	0.000161	0.000742	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—pancreatic cancer	0.00016	0.000737	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—pancreatic cancer	0.000158	0.000731	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—pancreatic cancer	0.000156	0.000722	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000153	0.000708	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—pancreatic cancer	0.000153	0.000707	CcSEcCtD
Abiraterone—Constipation—Epirubicin—pancreatic cancer	0.000152	0.000702	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00015	0.000692	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—pancreatic cancer	0.000149	0.000687	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000146	0.000677	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000145	0.000668	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000142	0.000655	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—pancreatic cancer	0.000142	0.000655	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—pancreatic cancer	0.00014	0.000649	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—pancreatic cancer	0.00014	0.000649	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—pancreatic cancer	0.00013	0.0006	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—pancreatic cancer	0.000127	0.000589	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—pancreatic cancer	0.000121	0.000561	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—pancreatic cancer	0.000118	0.000545	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—pancreatic cancer	0.000113	0.000522	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000112	0.000519	CcSEcCtD
Abiraterone—Rash—Epirubicin—pancreatic cancer	0.000112	0.000517	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—pancreatic cancer	0.000112	0.000517	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—pancreatic cancer	0.000104	0.000483	CcSEcCtD
Abiraterone—Rash—Doxorubicin—pancreatic cancer	0.000104	0.000479	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—pancreatic cancer	0.000103	0.000478	CcSEcCtD
Abiraterone—CYP3A4—digestive system—pancreatic cancer	7.69e-05	0.0232	CbGeAlD
Abiraterone—CYP2D6—digestive system—pancreatic cancer	7.57e-05	0.0228	CbGeAlD
